Biotech

All Articles

Phase 3 Historian Rock test reaches SMA target, sending stock up 200%

.A phase 3 test of Intellectual Rock's vertebral muscle degeneration (SMA) prospect has actually str...

CAMP 4 is most current to eye IPO, while Upstream point out $182M planning

.RNA biotech CAMP4 Therapeutics has actually marked out prepare for a $67 thousand IPO, along with i...

Galecto purchases leukemia drug, falls bone tissue cancer cells resource in pivot

.A year after the failure of an idiopathic pulmonary fibrosis prospect delivered Galecto on a seek r...

Judo throws down $100M to knock senseless renal health condition

.Taking the floor covering is actually Judo Biography, a promising biotech equipped along with $100 ...

AstraZeneca pays for CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has actually paid CSPC Pharmaceutical Group $100 thousand for a preclinical cardiovascu...

Zephyrm seeks Hong Kong IPO to finance phase 3 tissue therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, submission (PDF) for an IPO to ...

Frazier Lifestyle Sciences collects $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has sourced an additionally $630 million for its fund focused on tiny as ...

GigaGen garners as much as $135M BARDA dollars to hammer botox

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own techni...

GPCR organization Septerna declare IPO on stamina of preclinical information

.Septerna is about to determine exactly how a biotech without "any sort of purposeful clinical data"...

Kurma shuts initially $154M haul for most significant biotech fund yet

.European VC agency Kurma Partners has actually introduced its latest biotech fund, along with 140 m...